Publications

Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.

Author(s): Haas EJ, McLaughlin JM, Khan F, Angulo FJ, Anis E, Lipsitch M, Singer SR, Mircus G, Brooks N, Smaja M, Pan K, Southern J, Swerdlow DL, Jodar L, Levy Y, Alroy-Preis S|Journal: Lancet Infect Dis|PMID: 34562375| September 2021

On Dec 20, 2020, Israel initiated a nationwide COVID-19 vaccination campaign for people aged 16 years and older and exclusively…

Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study.

Author(s): Peak CM, Kahn R, Grad YH, Childs LM, Lipsitch M, Buckee CO|Journal: Lancet Infect Dis|PMID: 32445710| May 2020

Voluntary individual quarantine and voluntary active monitoring of contacts are core disease control strategies for emerging infectious diseases such as…

Testing COVID-19 therapies to prevent progression of mild disease.

Author(s): Lipsitch M, Waldor MK|Journal: Lancet Infect Dis|PMID: 32618282| May 2020

A randomised controlled trial found no significant benefit of lopinavir-ritonavir over placebo in patients with severe corona-virus disease 2019 (COVID-19). Even…

Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China.

Author(s): Niehus R, De Salazar PM, Taylor AR, Lipsitch M|Journal: Lancet Infect Dis|PMID: 32246905| April 2020

The incidence of coronavirus disease 2019 (COVID-19) in Wuhan, China, has been estimated using imported case counts of international travellers,…

Estimating case fatality rates of COVID-19.

Author(s): Lipsitch M|Journal: Lancet Infect Dis|PMID: 32243813| March 2020

In their Correspondence, David Baud and colleagues suggest that case fatality rates (CFRs) for coronavirus disease 2019 have been underestimated…

Pneumococcal conjugate vaccines in different settings – Authors’ reply.

Author(s): Hanage WP, Lewnard JA|Journal: Lancet Infect Dis|PMID: 31782391| December 2019

We are grateful to William P Hausdorff for his interesting letter regarding our Personal View on the perplexing variation in…

Making sense of differences in pneumococcal serotype replacement.

Author(s): Lewnard JA, Hanage WP|Journal: Lancet Infect Dis|PMID: 30709666| February 2019

Serotype replacement in invasive pneumococcal disease threatens to undermine the most costly vaccination programme currently undertaken. However, the effects of…

Multidrug-resistant Neisseria gonorrhoeae: implications for future treatment strategies.

Author(s): MacFadden DR, Lipsitch M, Olesen SW, Grad Y|Journal: Lancet Infect Dis|PMID: 29856349| June 2018

Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling study.

Author(s): Leung K, Lipsitch M, Yuen KY, Wu JT|Journal: Lancet Infect Dis|PMID: 27914853| March 2017

Antivirals (eg, oseltamivir) are important for mitigating influenza epidemics. In 2007, an oseltamivir-resistant influenza seasonal A H1N1 strain emerged and…

Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.

Author(s): Grad YH, Kirkcaldy RD, Trees D, Dordel J, Harris SR, Goldstein E, Weinstock H, Parkhill J, Hanage WP, Bentley S, Lipsitch M|Journal: Lancet Infect Dis|PMID: 24462211| March 2014

The emergence of Neisseria gonorrhoeae with decreased susceptibility to extended spectrum cephalosporins raises the prospect of untreatable gonorrhoea. In the…